A Phase 3, Double-Blind, Multi-Center, Non-Inferiority, Randomized Study To Examine the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil in De Novo Adult Kidney Transplantation: Baseline Characteristics.

被引:0
作者
Rostaing, L. [1 ]
Budde, K. [2 ]
Bunnapradist, S. [3 ]
机构
[1] Univ Hosp Toulouse Rangueil, Toulouse, France
[2] Charite, Dept Nephrol, D-13353 Berlin, Georgia, Germany
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:339 / 339
页数:1
相关论文
共 21 条
[21]   Higher Initial Exposure of Envarsus Immediately Post Transplantation Is Not Associated With Increased Risk of Delayed Graft Function in Kidney Transplant Patients Treated With Novel Once-Daily MeltDose Tacrolimus (Envarsus) Vs. Twice-Daily Tacrolimus (Prograf): Results From a Phase 3, Double-Blind, Double-Dummy, Multi-Center, Randomized Trial [J].
Budde, K. ;
Silva, H. ;
Steinberg, S. ;
Kamar, N. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 :460-460